# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming bina...
RBC Capital analyst Brian Abrahams initiates coverage on Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform rating and a...